Categories: BrainNews

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal third quarter ended June 30, 2025, before market open on August 14, 2025.

Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Thursday, May 14, 2025, to discuss the Company’s third quarter fiscal year 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

Third Quarter 2025 Earnings Conference Call
Date: Thursday, August 14, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 939482
Webcast: 3Q Webcast Link

Please join at least five minutes before the start of the call to ensure timely participation.

A playback of the call will be available through Thursday, August 28, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 52598. A webcast replay will also be available using the webcast link above through August 28, 2025.

About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.

IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us

Staff

Recent Posts

Adia Nutrition Promotes Emmanuela Derisbrun, APRN, FNP-C, to Provider Role Amid Growing Patient Demand and Launch of Autism IRB Study

Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through…

41 minutes ago

MOVA Life brings its smart health home vision to Silicon Valley

SAN JOSE, Calif., Jan. 15, 2026 /PRNewswire/ -- Global smart technology brand MOVA hosted its…

41 minutes ago

LEADOPTIK Announces FDA Clearance of the LIA™ for Lung Biopsy Procedures

SAN JOSE, Calif., Jan. 15, 2026 /PRNewswire/ -- LEADOPTIK, Inc. today announced U.S. Food and…

41 minutes ago

BODYWELLE Now Offers FDA-Approved Oral Wegovy, the First Oral GLP-1 for Medical Weight Management

The Miami Beach-based practice integrates the newly approved oral GLP-1 into its physician-supervised weight management…

41 minutes ago

NCQA Appoints Dana Erickson and Kate McEvoy to Board of Directors

Nationally recognized healthcare leaders will bring fresh insight to advance NCQA's work in quality and…

42 minutes ago

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026

Registration Link for Phio's Presentation on Thursday, January 22 at 1:45 PM ETKing of Prussia,…

4 hours ago